Table of Contents
ISRN Obstetrics and Gynecology
Volume 2012, Article ID 481870, 6 pages
http://dx.doi.org/10.5402/2012/481870
Clinical Study

Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Suppressant (Liquid Gaviscon) for the Treatment of Heartburn during Pregnancy

1Technostics Limited, Daisy Building (2nd Floor), Castle Hill Hospital, Castle Road, Kingston Upon Hull HU16 5JQ, UK
2Medical Centre, Netcare Linksfield Hospital, Suite 205, 12th Avenue, Linksfield West, Johannesburg 2037, South Africa
3Elm Lane Surgery, Sheffield S5 7TW, UK
4Department of Obstetrics & Gynaecology, Hull Royal Infirmary, Anlaby Road, Kingston Upon Hull HU3 2JZ, UK
5Global Professional Relations, Reckitt Benckiser Group plc, 103-105 Bath Road, Slough SL1 3UH, UK

Received 26 September 2012; Accepted 3 October 2012

Academic Editors: S. Palomba and C. M. Peterson

Copyright © 2012 Vicki Strugala et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Vicki Strugala, Julian Bassin, Valerie S. Swales, Stephen W. Lindow, Peter W. Dettmar, and Edward C. M. Thomas, “Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Suppressant (Liquid Gaviscon) for the Treatment of Heartburn during Pregnancy,” ISRN Obstetrics and Gynecology, vol. 2012, Article ID 481870, 6 pages, 2012. https://doi.org/10.5402/2012/481870.